Page 1 | Search Results | Molecular Cancer Therapeutics | American Association for Cancer Research

1-11 of 11

Sort by

Sort Order Select

Journal Articles

(+)-JJ-74–138 is a Novel Noncompetitive Androgen Receptor Antagonist

Ryan N. Cole, Wei Chen, Laura E. Pascal, Joel B. Nelson, Peter Wipf, Zhou Wang

Mol Cancer Ther (2022) 21 (4): 483–492.

https://doi.org/10.1158/1535-7163.MCT-21-0432

Published: 01 April 2022

View article titled, (+)-JJ-74–138 is a Novel Noncompetitive Androgen Receptor Antagonist

Includes: Supplementary data

Journal Articles

EMT-Induced Gemcitabine Resistance in Pancreatic Cancer Involves the Functional Loss of Equilibrative Nucleoside Transporter 1

Brenna Weadick, Debasis Nayak, Avinash K. Persaud, Sau Wai Hung, Radhika Raj, Moray J. Campbell, Wei Chen, Junan Li, Terence M. Williams, Rajgopal Govindarajan

Mol Cancer Ther (2021) 20 (2): 410–422.

https://doi.org/10.1158/1535-7163.MCT-20-0316

Published: 05 February 2021

View article titled, EMT-Induced Gemcitabine Resistance in Pancreatic Cancer Involves the Functional Loss of Equilibrative Nucleoside Transporter 1

Includes: Multimedia, Supplementary data

Journal Articles

A Novel Small Molecule Targets Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancer

Zhenyu Yang, Dan Wang, James K. Johnson, Laura E. Pascal, Keita Takubo, Raghunandan Avula, Anish Bhaswanth Chakka, Jianhua Zhou, Wei Chen, Mingming Zhong, Qiong Song, Hui Ding, Zeyu Wu, Uma R. Chandran, Taber S. Maskrey, Joel B. Nelson, Peter Wipf, Zhou Wang

Mol Cancer Ther (2020) 19 (1): 75–88.

https://doi.org/10.1158/1535-7163.MCT-19-0489

Published: 03 January 2020

View article titled, A Novel Small Molecule Targets Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancer

Includes: Supplementary data

Journal Articles

Preclinical Efficacy and Safety Comparison of CD3 Bispecific and ADC Modalities Targeting BCMA for the Treatment of Multiple Myeloma

Mol Cancer Ther (2019) 18 (11): 2008–2020.

https://doi.org/10.1158/1535-7163.MCT-19-0007

Published: 01 November 2019

View article titled, Preclinical Efficacy and Safety Comparison of CD3 Bispecific and ADC Modalities Targeting BCMA for the Treatment of Multiple Myeloma

Includes: Supplementary data

Journal Articles

Nuclear Export of Ubiquitinated Proteins Determines the Sensitivity of Colorectal Cancer to Proteasome Inhibitor

Tingyu Wu, Wei Chen, Yongwang Zhong, Xiaodan Hou, Shengyun Fang, Chen-Ying Liu, Guanghui Wang, Tong Yu, Yu-Yang Huang, Xuesong Ouyang, Henry Q.X. Li, Long Cui, Yili Yang

Mol Cancer Ther (2017) 16 (4): 717–728.

https://doi.org/10.1158/1535-7163.MCT-16-0553

Published: 02 April 2017

View article titled, Nuclear Export of Ubiquitinated Proteins Determines the Sensitivity of Colorectal Cancer to Proteasome Inhibitor

Includes: Supplementary data

Journal Articles

Abstract B19: Anti-VEGF treatment normalizes tuberculosis granuloma vasculature and improves small molecule delivery

Meenal Datta, Laura E. Via, Walid S. Kamoun, Chong Liu, Wei Chen, Giorgio Seano, Danielle M. Weiner, Daniel Schimel, Kathleen England, John D. Martin, Xing Gao, Lei Xu, Clifton E. Barry, III, Rakesh K. Jain

Mol Cancer Ther (2015) 14 (12_Supplement_1): B19.

https://doi.org/10.1158/1538-8514.TUMANG15-B19

Published: 01 December 2015

View article titled, Abstract B19: Anti-VEGF treatment normalizes tuberculosis granuloma vasculature and improves small molecule delivery

Journal Articles

Inhibition of mTORC2 Induces Cell-Cycle Arrest and Enhances the Cytotoxicity of Doxorubicin by Suppressing MDR1 Expression in HCC Cells

Bryan Wei Chen, Wei Chen, Hui Liang, Hao Liu, Chao Liang, Xiao Zhi, Li-qiang Hu, Xia-Zhen Yu, Tao Wei, Tao Ma, Fei Xue, Lei Zheng, Bin Zhao, Xin-Hua Feng, Xue-li Bai, Ting-bo Liang

Mol Cancer Ther (2015) 14 (8): 1805–1815.

https://doi.org/10.1158/1535-7163.MCT-15-0029

Published: 05 August 2015

View article titled, Inhibition of mTORC2 Induces Cell-Cycle Arrest and Enhances the Cytotoxicity of Doxorubicin by Suppressing MDR1 Expression in HCC Cells

Includes: Supplementary data

Journal Articles

Inhibition of Protein Phosphatase 2A Enhances Cytotoxicity and Accessibility of Chemotherapeutic Drugs to Hepatocellular Carcinomas

Xue-Li Bai, Qi Zhang, Long-Yun Ye, Qi-Da Hu, Qi-Han Fu, Xiao Zhi, Wei Su, Ri-Ga Su, Tao Ma, Wei Chen, Shang-Zhi Xie, Cong-Lin Chen, Ting-Bo Liang

Mol Cancer Ther (2014) 13 (8): 2062–2072.

https://doi.org/10.1158/1535-7163.MCT-13-0800

Published: 05 August 2014

View article titled, Inhibition of Protein Phosphatase 2A Enhances Cytotoxicity and Accessibility of Chemotherapeutic Drugs to Hepatocellular Carcinomas

Includes: Supplementary data

Journal Articles

Abstract B259: Novel indolizino[6,7-b]indoles suppress the growth of human non-small cell lung cancer cells in xenografted and orthotopic mouse models via induction of DNA crosslinks and inhibition of topoisomerase I and II.

Chi-Wei Chen, Yi-Fan Chen, Shu-Hsin Chao, Satishkumar Tala, Tsann-Long Su, Te-Chang Lee

Mol Cancer Ther (2013) 12 (11_Supplement): B259.

https://doi.org/10.1158/1535-7163.TARG-13-B259

Published: 01 November 2013

View article titled, Abstract B259: Novel indolizino[6,7-b]indoles suppress the growth of human non-small cell lung cancer cells in xenografted and orthotopic mouse models via induction of DNA crosslinks and inhibition of topoisomerase I and II.

Journal Articles

Cucurbitacin I Suppressed Stem-Like Property and Enhanced Radiation-Induced Apoptosis in Head and Neck Squamous Carcinoma–Derived CD44⁺ALDH1⁺ Cells

Yi-Wei Chen, Kuan-Hsuan Chen, Pin-I Huang, Yu-Chih Chen, Guang-Yu Chiou, Wen-Liang Lo, Ling-Ming Tseng, Han-Sui Hsu, Kuo-Wei Chang, Shih-Hwa Chiou

Mol Cancer Ther (2010) 9 (11): 2879–2892.

https://doi.org/10.1158/1535-7163.MCT-10-0504

Published: 09 November 2010

View article titled, Cucurbitacin I Suppressed Stem-Like Property and Enhanced Radiation-Induced Apoptosis in Head and Neck Squamous Carcinoma–Derived CD44+ALDH1+ Cells

Includes: Supplementary data

Journal Articles

Abstract A70: A genome‐wide siRNA screen for modulators of cell death induced by the proteasome inhibitor bortezomib

Mol Cancer Ther (2009) 8 (12_Supplement): A70.

https://doi.org/10.1158/1535-7163.TARG-09-A70

Published: 10 December 2009

View article titled, Abstract A70: A genome‐wide siRNA screen for modulators of cell death induced by the proteasome inhibitor bortezomib

NARROW

(+)-JJ-74–138 is a Novel Noncompetitive Androgen Receptor Antagonist

EMT-Induced Gemcitabine Resistance in Pancreatic Cancer Involves the Functional Loss of Equilibrative Nucleoside Transporter 1

A Novel Small Molecule Targets Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancer

Preclinical Efficacy and Safety Comparison of CD3 Bispecific and ADC Modalities Targeting BCMA for the Treatment of Multiple Myeloma

Nuclear Export of Ubiquitinated Proteins Determines the Sensitivity of Colorectal Cancer to Proteasome Inhibitor

Abstract B19: Anti-VEGF treatment normalizes tuberculosis granuloma vasculature and improves small molecule delivery

Inhibition of mTORC2 Induces Cell-Cycle Arrest and Enhances the Cytotoxicity of Doxorubicin by Suppressing MDR1 Expression in HCC Cells

Inhibition of Protein Phosphatase 2A Enhances Cytotoxicity and Accessibility of Chemotherapeutic Drugs to Hepatocellular Carcinomas

Abstract B259: Novel indolizino[6,7-b]indoles suppress the growth of human non-small cell lung cancer cells in xenografted and orthotopic mouse models via induction of DNA crosslinks and inhibition of topoisomerase I and II.

Cucurbitacin I Suppressed Stem-Like Property and Enhanced Radiation-Induced Apoptosis in Head and Neck Squamous Carcinoma–Derived CD44⁺ALDH1⁺ Cells

Abstract A70: A genome‐wide siRNA screen for modulators of cell death induced by the proteasome inhibitor bortezomib

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only